Ahmedabad based JVS Technologies Pvt Ltd launches SoftClinic GenX: India’s first ZERO Cost AI-Powered Digital Prescription App

September 27: One of the leading Health-tech company, JVS Technologies Pvt Ltd, introduces SoftClinic GenX: India’s first ZERO-cost AI-powered digital health-tech platform for adopting digital prescriptions in India. This helps doctors prepare prescriptions in seconds and send them to patients over WhatsApp, Email & SMS without typing anything. It is a touch-based app powered by artificial intelligence and machine learning that aims to minimize the time taken to prepare prescriptions compared to the time taken to write on paper or typing it on computers. This also helps doctors increase their efficiency and accuracy and reduce fatigue due to writing multiple prescriptions throughout the day along with providing them access to patient records anywhere-anytime.

As per the CEO, Mr. Saket Singhi, In the Indian market, where there are more than 4 billion prescriptions written yearly, SoftClinic GenX is on a mission for adoption of digital prescriptions, which will result in significantly reducing the use of paper and decrease waiting time for patients by eliminating repetitive data entry at each touch points.

With SoftClinic GenX, physicians will start their journey toward truly paperless practice. It has inbuilt highly secured telemedicine features to help do follow-up consultations with patients over the phone or tablets, or any computer device.

Personalized artificial intelligence and machine learning help physicians prepare prescriptions within seconds by simply selecting from suggestions. On completion of the consultation, a prescription is digitally sent to patients on their WhatsApp, SMS & Email as well as patients can access the prescription from the SoftClinic GenX Care App, which is specially designed to keep all medical records organized for the patient and their family members.

It’s the latest and greatest product from the house of JVS Group, which has two decades-long expertise in the Health-Tech domain. With the introduction of SoftClinic GenX, the primary goals are to eliminate the trust deficit between patients and doctors, reduce waiting time for patients and save the environment by reducing the use of papers in clinics and hospitals.

From its humble beginnings as a clinical software solution provider in 2002, JVS has evolved and grown multifold over the years. The company now offers software solutions in 45+ countries and, with its flagship product SoftClinic, has served more than 5 million patients to this day. SoftClinic has been in the market since 2010, and it has been awarded the best clinic & hospital management software (HMS) by customers, Silicon Reviews, SoftwareSuggest, Capterra, etc. With the launch of SoftClinic GenX, JVS plans to expand its presence worldwide.

SoftClinic GenX digital health-tech platform offers a connected solution for all healthcare professionals to connect patients with clinics, laboratories, pharmacy & hospitals. Bringing all these amazing medical tech support services under an umbrella is only possible due to the implementation of artificial intelligence. AI offers a significant edge in analytics and decision-making over traditional methods. SoftClinic GenX takes full advantage of AI and ML in capturing, storing with encryption, and analyze data from day-to-day operations.

If you’re a physician still writing / printing prescriptions on paper, laboratory still giving reports on paper, a pharmacy still creating manual/computerized bills, or a hospital still using all printouts, then you should register and start using SoftClinic GenX today.

With the launch, SoftClinic GenX is offering exciting free wallet credit offers to the first 1000 signups.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business

MIRC Electronics Limited Announces Rights Issue Opening on July 14, 2025

Mumbai (Maharashtra) [India], July 15: MIRC Electronics Limited (NSE Code: MIRCELECTR, BSE Code: 500279), renowned for its legacy in electronics and home appliances, opens its Rights Issue on Monday, July 14, 2025, aiming to raise ₹ 49.49Crore. The issue size is 4,94,89,847 equity shares at a face value of ₹1 each with an Issue Price of ₹ 10 Per Share. Rights Issue details: ● Right Issue […]

Read More
Business

Bluegod Entertainment To Consider And Approve Stock Split; Board Of Directors Meeting On 16 July

New Delhi [India], July 14:  Board of Directors of Bluegod Entertainment Limited (BSE – 539175), formerly known as Indra Industries Limited, is scheduled to meet on 16th July 2025 to consider and approve the proposal for stock split/subdivision of equity shares of the company. Currently face value of the company share is Rs. 10 per share. […]

Read More
Business

TripleCare Revolutionizes Haircare with a Breakthrough 3-in-1 Formula

New Delhi [India], July 11: What began as a vision by founder Rohit Rana—to simplify haircare without compromising on quality—has evolved into TripleCare, India’s trusted 3-in-1 haircare innovation. TripleCare merges the benefits of shampoo, conditioner, and hair oil into one smart solution tailored for modern lifestyles. With its unique formulation, TripleCare ensures deep cleansing, intensive […]

Read More